In particular, the authors analyze different, multivalent bindings for cystic fibrosis transmembrane conductance regulator (CFTR) and for the PD multi-domain kinase LRRK2, which present nine and six binding sites for 14-3-3s, respectively. Here, LRRK2 is linked to Parkinson disease.